Associate Professor Simon Leedham has been named as the new Director of the Centre for Personalised Medicine (CPM), joining existing staff Martijn van de Bunt, Catherine Lidbetter and Thea Perry in May 2016.
Simon is a Cancer Research UK Clinician Scientist and an Honorary Consultant Gastroenterologist. His current research at the Wellcome Trust Centre for Human Genetics (WTCHG) focuses on the cell-signalling pathways that control intestinal stem cells and the dysregulation of these pathways in cancer. Speaking of his new appointment, Simon says:
“Harnessing the power of rapidly improving sequencing technology for the benefit of patient management is at the cutting edge of modern clinical medicine. I’m thrilled to be taking over the Directorship of the Oxford Centre for Personalised Medicine to help highlight the potential, and address the challenges, of integrating genomics and patient care.”
Professor Peter Donnelly, Director of the Wellcome Trust Centre for Human Genetics, welcomes Simon’s appointment:
“Simon is a leading practicing clinician and research scientist in his field. He is an excellent communicator, bringing real enthusiasm to this role.”
The CPM is an innovative partnership between the Wellcome Trust Centre for Human Genetics and St. Anne’s College at the University of Oxford. As rapid advances of new technologies expand the knowledge of genetic variation and its relevance to human disease, the Centre provides an inter-disciplinary environment for the exchange of knowledge, helping to drive forward a more integrated and personalised approach to medicine and healthcare.
Further information about the Centre for Personalised Medicine can be found here.